BioPharma Asia is the premier publication for unbiased, cutting edge editorial written by the leading figures currently working in the global Pharma and BioPharma industry. With a circulation of 30,000 printed journals throughout Asia and distributed to a controlled circulation of Heads of Manufacturing, Senior Scientists and Middle-Senior Managers throughout Asia on a bi-monthly basis, BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.